Silvercrest Asset Management Group Llc increased its stake in Aflac Inc Com (AFL) by 397.9% based on its latest 2019Q1 regulatory filing with the SEC. Silvercrest Asset Management Group Llc bought 34,235 shares as the company’s stock rose 4.82% . The hedge fund held 42,839 shares of the accident &health insurance company at the end of 2019Q1, valued at $2.14 million, up from 8,604 at the end of the previous reported quarter. Silvercrest Asset Management Group Llc who had been investing in Aflac Inc Com for a number of months, seems to be bullish on the $38.74B market cap company. The stock decreased 1.06% or $0.56 during the last trading session, reaching $52.32. About 1.95 million shares traded. Aflac Incorporated (NYSE:AFL) has risen 13.62% since August 13, 2018 and is uptrending. It has outperformed by 13.62% the S&P500. Some Historical AFL News: 11/04/2018 – April 16th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aflac Incorporated (AFL); 25/04/2018 – AFLAC INC – IN YEN TERMS, AFLAC JAPAN’S PREMIUM INCOME, NET OF REINSURANCE, WAS ¥353.3 BLN IN QTR , OR 2.6% LOWER THAN A YEAR AGO; 17/05/2018 – Aflac Delivers Contemporary Solutions to Improve Care for Today’s Cancer Patients; 08/03/2018 – The Klein Law Firm Reminds Investors of a Class Action on Behalf of Aflac Incorporated Shareholders and a Lead Plaintiff Deadline of April 16, 2018 (AFL); 17/04/2018 – Country Music Star Chris Young Joins Aflac to Present First-Ever Aflac ACM Lifting Lives Honor for Excellence in Music Therapy; 03/04/2018 – Aflac Names J. Todd Daniels as EVP; Principal Financial Officer, Aflac Japan and Albert A. Riggieri as SVP, Global Chief Risk Officer and Chief Actuary, Aflac Incorporated; 04/04/2018 – Aflac Recognized for Social Responsibility; 02/04/2018 – S&PGR Rates Aflac Life Insurance Japan ‘A+’; Otlk Stable; 02/04/2018 – A.M. Best Assigns Credit Ratings to Aflac’s New Japan Subsidiary; Affirms Credit Ratings of U.S. Insurance Subsidiaries; 08/03/2018 – The Klein Law Firm Reminds Investors of a Class Action on Behalf of Aflac Incorporated Shareholders and a Lead Plaintiff Deadli
Mark Sheptoff Financial Planning Llc decreased its stake in Abbvie Inc (ABBV) by 42.27% based on its latest 2019Q1 regulatory filing with the SEC. Mark Sheptoff Financial Planning Llc sold 18,452 shares as the company’s stock declined 15.55% . The institutional investor held 25,198 shares of the major pharmaceuticals company at the end of 2019Q1, valued at $2.03 million, down from 43,650 at the end of the previous reported quarter. Mark Sheptoff Financial Planning Llc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $95.41 billion market cap company. The stock decreased 1.60% or $1.05 during the last trading session, reaching $64.53. About 5.61M shares traded. AbbVie Inc. (NYSE:ABBV) has declined 27.15% since August 13, 2018 and is downtrending. It has underperformed by 27.15% the S&P500. Some Historical ABBV News: 02/04/2018 – Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDA® (Pembrolizumab) Combination Trials; 24/04/2018 – AstraZeneca: Negative Results From Phase 3 Trial of Imfinzi and Tremelimumab; 22/03/2018 – ABBVIE INC – WILL NOT SEEK ACCELERATED APPROVAL FOR ROVA-T IN THIRD-LINE RELAPSED/REFRACTORY SMALL CELL LUNG CANCER; 20/04/2018 – Jennison Adds Hill-Rom, Exits Cooper Cos, Cuts AbbVie; 07/05/2018 – REG-Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma; 25/04/2018 – ABBVIE INC – SIGNIFICANTLY MORE PATIENTS RECEIVING UPADACITINIB ACHIEVED ACR50, ACR70 AND CLINICAL REMISSION AT WEEK 12 COMPARED TO PLACEBO; 30/05/2018 – AbbVie Announces Preliminary Results of Tender Offer; 26/04/2018 – AbbVie to Commence Self-Tender Offer for Up to $7.5B of Common Stk; 30/05/2018 – GILEAD SCIENCES INC – EPCLUSA IS FIRST PAN-GENOTYPIC HCV SINGLE TABLET REGIMEN (STR) APPROVED IN CHINA; 26/04/2018 – S&PGRBulletin: AbbVie Rtgs Unaffected By Share Repurchase Plan
Investors sentiment is 0.83 in 2019 Q1. Its the same as in 2018Q4. It is flat, as 73 investors sold ABBV shares while 627 reduced holdings. only 134 funds opened positions while 450 raised stakes. 962.74 million shares or 3.37% less from 996.27 million shares in 2018Q4 were reported. 26,243 were accumulated by Covington Mgmt. Los Angeles Capital Management And Equity invested in 784,586 shares. Sonata Grp Inc Inc accumulated 3,420 shares or 0.21% of the stock. Meristem Family Wealth Lc has invested 0.25% in AbbVie Inc. (NYSE:ABBV). Penbrook Mgmt Limited Com stated it has 0.32% in AbbVie Inc. (NYSE:ABBV). Sfe Invest Counsel stated it has 1.95% of its portfolio in AbbVie Inc. (NYSE:ABBV). Bessemer Group holds 974,067 shares or 0.3% of its portfolio. Omers Administration reported 0.01% stake. Apriem holds 1.86% or 87,240 shares. Enterprise Financial has invested 0.3% in AbbVie Inc. (NYSE:ABBV). Moreover, Colony Gru Ltd has 0.07% invested in AbbVie Inc. (NYSE:ABBV). Cap Investors owns 146.51 million shares for 3.74% of their portfolio. Cambridge Advsr Inc has 0.32% invested in AbbVie Inc. (NYSE:ABBV) for 11,820 shares. Salem Capital Inc reported 0.18% in AbbVie Inc. (NYSE:ABBV). Moreover, Creative Planning has 0.1% invested in AbbVie Inc. (NYSE:ABBV).
Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on November, 1. They expect $2.27 EPS, up 6.07% or $0.13 from last year’s $2.14 per share. ABBV’s profit will be $3.36B for 7.11 P/E if the $2.27 EPS becomes a reality. After $2.26 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 0.44% EPS growth.
Since June 26, 2019, it had 9 buys, and 0 insider sales for $12.96 million activity. 30,400 shares valued at $2.05M were bought by CHASE WILLIAM J on Wednesday, June 26. Gosebruch Henry O bought $2.02M worth of stock or 30,000 shares. The insider AUSTIN ROXANNE S bought $663,500.
Mark Sheptoff Financial Planning Llc, which manages about $218.89 million and $138.78M US Long portfolio, upped its stake in Merck & Co Inc (NYSE:MRK) by 5,700 shares to 6,700 shares, valued at $557,000 in 2019Q1, according to the filing. It also increased its holding in At&T Inc (NYSE:T) by 14,470 shares in the quarter, for a total of 123,488 shares, and has risen its stake in Nextera Energy Inc (NYSE:NEE).
More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “AbbVie enters STING field with Mavupharma buy – Seeking Alpha” on July 15, 2019, also Seekingalpha.com with their article: “AbbVie Portfolio: Halftime Report – Seeking Alpha” published on August 04, 2019, Seekingalpha.com published: “AbbVie Will Be Formidable After Acquiring Allergan – Seeking Alpha” on August 07, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “AbbVie: Testing Our Capacity To Suffer – Seeking Alpha” published on August 08, 2019 as well as Seekingalpha.com‘s news article titled: “Newspaper Deal Stretches Limits Of Revival – Seeking Alpha” with publication date: August 13, 2019.
Since March 22, 2019, it had 1 buying transaction, and 0 insider sales for $99,659 activity.
Silvercrest Asset Management Group Llc, which manages about $15.87 billion and $10.17 billion US Long portfolio, decreased its stake in Rogers Corp Com (NYSE:ROG) by 21,510 shares to 381,367 shares, valued at $60.59 million in 2019Q1, according to the filing. It also reduced its holding in Waste Connections Inc Com by 10,671 shares in the quarter, leaving it with 607,750 shares, and cut its stake in Msa Safety Inc Com (NYSE:MSA).
More notable recent Aflac Incorporated (NYSE:AFL) news were published by: 247Wallst.com which released: “Top Analyst Upgrades and Downgrades: AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack, Wingstop and More – 24/7 Wall St.” on July 16, 2019, also Bizjournals.com with their article: “Aflac Inc. agrees to acquire Florida-based dental and vision benefits provider – Atlanta Business Chronicle” published on July 17, 2019, Seekingalpha.com published: “Aflac Q2 EPS beats, reaffirms 2019 guidance – Seeking Alpha” on July 25, 2019. More interesting news about Aflac Incorporated (NYSE:AFL) were released by: Finance.Yahoo.com and their article: “What Makes Aflac Incorporated (NYSE:AFL) A Great Dividend Stock? – Yahoo Finance” published on June 07, 2019 as well as Seekingalpha.com‘s news article titled: “Raymond James a little less bullish on Aflac – Seeking Alpha” with publication date: July 29, 2019.
Investors sentiment decreased to 0.81 in Q1 2019. Its down 0.06, from 0.87 in 2018Q4. It is negative, as 42 investors sold AFL shares while 320 reduced holdings. 87 funds opened positions while 206 raised stakes. 471.73 million shares or 2.76% less from 485.14 million shares in 2018Q4 were reported. Moreover, Stratos Wealth Limited has 0.04% invested in Aflac Incorporated (NYSE:AFL) for 16,343 shares. Colony Group Inc Ltd Com invested in 5,869 shares. Drexel Morgan has invested 0.21% of its portfolio in Aflac Incorporated (NYSE:AFL). Financial Bank Of Montreal Can holds 1.49M shares or 0.06% of its portfolio. 349,611 are held by Envestnet Asset Mgmt. Citigroup holds 0.02% or 425,853 shares. Duncker Streett And has invested 0.24% of its portfolio in Aflac Incorporated (NYSE:AFL). Sabal reported 2.54% in Aflac Incorporated (NYSE:AFL). Meeder Asset Mgmt Inc holds 0.11% of its portfolio in Aflac Incorporated (NYSE:AFL) for 28,582 shares. Tctc Holdings Ltd Com has 855,180 shares. Nomura Asset Mgmt Communication Limited invested in 0.09% or 179,298 shares. Merian Glob (Uk) Limited stated it has 1.71 million shares or 0.79% of all its holdings. Moreover, Baystate Wealth Mngmt Ltd Co has 0% invested in Aflac Incorporated (NYSE:AFL). Tradewinds Capital Mngmt Limited Liability Corporation owns 310 shares. Tru Commerce Of Vermont holds 0.17% or 39,098 shares in its portfolio.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.